“…Epidemiologically, infection with P. falciparum malaria is severe and can be lethal in endemic countries including Thailand. At present, anti-malarial drugs, such as pyrimethamine (PYR), chloroquine (CQ), artemisinin (ART), cycloguanil, quinidine, amodiaquine and mefloquine, are used for the treatment of malaria; however, the emergence of drug resistance has become a significant concern [ 1 , 2 , 3 ]. Thus, an iron chelator may be used as an adjunctive anti-malarial drug to inhibit malaria growth and infection by depriving parasites of the iron which is essential for their survival [ 4 , 5 ].…”